BBS-Bioactive Bone Substitutes (OHEL:BONEH) Net Issuance of Debt : €-0.50 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BBS-Bioactive Bone Substitutes Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. BBS-Bioactive Bone Substitutes's net issuance of debt for the six months ended in Dec. 2023 was €-0.46 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.50 Mil.

BBS-Bioactive Bone Substitutes Net Issuance of Debt Historical Data

The historical data trend for BBS-Bioactive Bone Substitutes's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BBS-Bioactive Bone Substitutes Net Issuance of Debt Chart

BBS-Bioactive Bone Substitutes Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Debt

Get a 7-Day Free Trial

-0.32

0.44

-0.53

-0.50

BBS-Bioactive Bone Substitutes Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Issuance of Debt	Get a 7-Day Free Trial											0.48	0.20	-0.74	-0.05	-0.46

BBS-Bioactive Bone Substitutes Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.50 Mil.

BBS-Bioactive Bone Substitutes Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of BBS-Bioactive Bone Substitutes's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kiviharjunlenkki 6, Oulu, FIN, 90220

Website

http://www.bbs-artebone.fi

BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Headlines

No Headlines